XORTX Therapeutics XRTX
NASDAQ XRTX
$1.69 -0.01 (-0.59%)
At close: Sep 30, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Cash from Operations (2022)

Updated

XORTX Therapeutics' Cash from Operations was -$2.77 million in the year ended Dec 31, 2025, compared with -$3.68 million a year earlier.

Analysis

XORTX Therapeutics (XRTX) Cash from Operations (2022) Analysis & Trends

From the year ended Dec 31, 2019 onward, XORTX Therapeutics has reported Cash from Operations for 7 years.

  • The figure for the year ended Dec 31, 2025 marks the highest annual Cash from Operations since the year ended Dec 31, 2020.
  • Per Business Quant data, Cash from Operations in earlier years was -$3.68 million in the year ended Dec 31, 2024, -$6.58 million in the year ended Dec 31, 2023, -$8.17 million in the year ended Dec 31, 2022 and -$4.8 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 8.62 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 3.44 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 4.58 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 3.57 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.13 Bn
10 XORTX Therapeutics 1.61 Mn -1.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -3.80 Mn
Sep 30, 2022 -951,535.92
API Access

XORTX Therapeutics Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=XRTX&period=max&api_key=YOUR_API_KEY